Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,291 USD | +1,89% | -13,00% | -79,06% |
Omzet 2022 | - | Omzet 2023 | 2,2 2,06 | Marktkapitalisatie | 13,61 mln. 12,73 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -73 mln. -68,27 mln. | Nettowinst (verlies) 2023 | -37 mln. -34,6 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 4,59 mln. 4,29 mln. | Nettoschuld 2023 | 11,23 mln. 10,5 mln. | EV/omzet 2023 | 11.278.477 x |
K/w-verhouding 2022 |
-0,98
x | K/w-verhouding 2023 |
-0,18
x | Werknemers | 16 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 98% |
Recentste transcriptie over Seelos Therapeutics, Inc.
1 dag | +1,89% | ||
1 week | -13,00% | ||
Lopende maand | -50,76% | ||
1 maand | -44,83% | ||
3 maanden | -72,80% | ||
6 maanden | -95,41% | ||
Lopend jaar | -79,06% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Raj Mehra
CEO | Chief Executive Officer | 64 | 01-01-87 |
Director of Finance/CFO | 52 | 01-01-19 | |
Karen Fusaro
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 77 | 01-09-21 | |
Richard Pascoe
BRD | Director/Board Member | 60 | 01-03-13 |
Daniel O'Connor
BRD | Director/Board Member | 59 | 01-01-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,291 | +1,89% | 556 743 |
25-04-24 | 0,2856 | -5,12% | 364 925 |
24-04-24 | 0,301 | -7,98% | 612 932 |
23-04-24 | 0,3271 | +0,43% | 383 907 |
22-04-24 | 0,3257 | -2,63% | 204 336 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-79,06% | 3,91 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,37% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,85% | 15,52 mld. | |
+3,21% | 13,86 mld. | |
+33,54% | 12,04 mld. |